Hao Zhang1,2, Heather Wheat1, Peter Wang1, Sha Jiang1, Helen A Baghdoyan1,3, Richard R Neubig4, X Y Shi5, Ralph Lydic1,3. 1. Department of Anesthesiology, University of Michigan, Ann Arbor, MI. 2. Department of Anesthesiology, The Second Artillery General Hospital, Beijing, China. 3. Departments of Anesthesiology and Psychology, University of Tennessee, Knoxville, TN. 4. Department of Pharmacology and Toxicology, Michigan State University, Lansing, MI. 5. Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Abstract
STUDY OBJECTIVES: This study tested the hypothesis that Regulators of G protein Signaling (RGS) proteins contribute to the regulation of wakefulness, non-rapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep, and to sleep disruption caused by volatile anesthetics. METHODS: The three groups used in this study included wild-type (WT; n = 7) mice and knock-in mice that were heterozygous (+/GS; n = 7) or homozygous (GS/GS; n = 7) for an RGS-insensitive allele that causes prolonged Gαi2 signaling. Mice were implanted with electrodes for recording sleep and conditioned for 1 week or more to sleep in the laboratory. Using within and between groups designs, 24-h recordings of wakefulness, NREM sleep, and REM sleep were compared across three interventions: (1) baseline (control) and after 3 h of being anesthetized with (2) isoflurane or (3) sevoflurane. RESULTS: Baseline recordings during the light phase revealed that relative to WT mice, homozygous RGS-insensitive (GS/GS) mice exhibit significantly increased wakefulness and decreased NREM and REM sleep. During the dark phase, these state-specific differences remained significant but reversed direction of change. After cessation of isoflurane and sevoflurane anesthesia there was a long-lasting and significant disruption of sleep and wakefulness. The durations of average episodes of wakefulness, NREM sleep, and REM sleep were significantly altered as a function of genotype and isoflurane and sevoflurane anesthesia. CONCLUSIONS: RGS proteins and Gαi2 play a significant role in regulating states of wakefulness, NREM sleep, and REM sleep. Genotype-specific differences demonstrate that RGS proteins modulate sleep disruption caused by isoflurane and sevoflurane anesthesia. The results also support the conclusion that isoflurane and sevoflurane anesthesia do not satisfy the homeostatic drive for sleep.
STUDY OBJECTIVES: This study tested the hypothesis that Regulators of G protein Signaling (RGS) proteins contribute to the regulation of wakefulness, non-rapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep, and to sleep disruption caused by volatile anesthetics. METHODS: The three groups used in this study included wild-type (WT; n = 7) mice and knock-in mice that were heterozygous (+/GS; n = 7) or homozygous (GS/GS; n = 7) for an RGS-insensitive allele that causes prolonged Gαi2 signaling. Mice were implanted with electrodes for recording sleep and conditioned for 1 week or more to sleep in the laboratory. Using within and between groups designs, 24-h recordings of wakefulness, NREM sleep, and REM sleep were compared across three interventions: (1) baseline (control) and after 3 h of being anesthetized with (2) isoflurane or (3) sevoflurane. RESULTS: Baseline recordings during the light phase revealed that relative to WT mice, homozygous RGS-insensitive (GS/GS) mice exhibit significantly increased wakefulness and decreased NREM and REM sleep. During the dark phase, these state-specific differences remained significant but reversed direction of change. After cessation of isoflurane and sevoflurane anesthesia there was a long-lasting and significant disruption of sleep and wakefulness. The durations of average episodes of wakefulness, NREM sleep, and REM sleep were significantly altered as a function of genotype and isoflurane and sevoflurane anesthesia. CONCLUSIONS: RGS proteins and Gαi2 play a significant role in regulating states of wakefulness, NREM sleep, and REM sleep. Genotype-specific differences demonstrate that RGS proteins modulate sleep disruption caused by isoflurane and sevoflurane anesthesia. The results also support the conclusion that isoflurane and sevoflurane anesthesia do not satisfy the homeostatic drive for sleep.
Authors: Xinyan Huang; Ying Fu; Raelene A Charbeneau; Thomas L Saunders; Douglas K Taylor; Kurt D Hankenson; Mark W Russell; Louis G D'Alecy; Richard R Neubig Journal: Mol Cell Biol Date: 2006-09 Impact factor: 4.272
Authors: Ying Fu; Xinyan Huang; Huailing Zhong; Richard M Mortensen; Louis G D'Alecy; Richard R Neubig Journal: Circ Res Date: 2006-02-02 Impact factor: 17.367
Authors: Max B Kelz; Yi Sun; Jingqiu Chen; Qing Cheng Meng; Jason T Moore; Sigrid C Veasey; Shelley Dixon; Marcus Thornton; Hiromasa Funato; Masashi Yanagisawa Journal: Proc Natl Acad Sci U S A Date: 2008-01-14 Impact factor: 11.205
Authors: Zeev N Kain; Linda C Mayes; Alison A Caldwell-Andrews; Gerianne M Alexander; Dawn Krivutza; Barbara A Teague; Shu-Ming Wang Journal: Anesthesiology Date: 2002-11 Impact factor: 7.892
Authors: Xiaoying Zhang; Aaron G Baer; Joshua M Price; Piet C Jones; Benjamin J Garcia; Jonathon Romero; Ashley M Cliff; Weidong Mi; James B Brown; Daniel A Jacobson; Ralph Lydic; Helen A Baghdoyan Journal: J Neurophysiol Date: 2020-04-29 Impact factor: 2.714